CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies
Clinical trial NCT04700319 · UNKNOWN
Trial details
- NCT number
- NCT04700319
- Sponsor
- PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-19
- Primary completion
- 2021-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.